Maximizing ovarian function and fertility following chemotherapy in premenopausal patients: Is there a role for ovarian suppression?
As more premenopausal patients undergo fertility preserving cancer treatments, there is an increased need for fertility counseling and ovarian sparing strategies. Many patients receive gonadotoxic chemotherapeutic agents which can put them at risk of primary ovarian insufficiency or profoundly dimin...
Saved in:
Main Authors: | Kelsey A. Roof (Author), Kerri E. Andre (Author), Susan C. Modesitt (Author), D. Austin Schirmer (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?
by: Matteo Lambertini, et al.
Published: (2019) -
Ovarian function suppression: To what extent is it necessary for premenopausal patients with operable hormone-sensitive breast cancer?
by: P. V. Koposov
Published: (2015) -
The role of Chito-oligosaccharide in regulating ovarian germ stem cells function and restoring ovarian function in chemotherapy mice
by: Yaoqi Huang, et al.
Published: (2021) -
Postoperative outcomes of ovarian preserving surgery in premenopausal women with adnexal torsion
by: Euna Choi, et al.
Published: (2023) -
Maximize the safety and efficacy of fertility preservation by random start/dual ovarian stimulation for early breast cancer patients
by: Shih-Hung Richard Young, et al.
Published: (2023)